Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM
Br J Psychiatry
.
2024 Aug;225(2):349.
doi: 10.1192/bjp.2024.189.
Epub 2024 Oct 14.
Authors
Colleen Loo
,
Nick Glozier
,
David Barton
,
Bernhard T Baune
,
Natalie T Mills
,
Paul Fitzgerald
,
Paul Glue
,
Shanthi Sarma
,
Veronica Galvez-Ortiz
,
Dusan Hadzi-Pavlovic
,
Angelo Alonzo
,
Vanessa Dong
,
Donel Martin
,
Stevan Nikolin
,
Philip B Mitchell
,
Michael Berk
,
Gregory Carter
,
Maree Hackett
,
John Leyden
,
Sean Hood
,
Andrew A Somogyi
,
Kyle Lapidus
,
Elizabeth Stratton
,
Kirsten Gainsford
,
Deepak Garg
,
Nicollette L R Thornton
,
Célia Fourrier
,
Karyn Richardson
,
Demi Rozakis
,
Anish Scaria
,
Cathrine Mihalopoulos
,
Mary Lou Chatterton
,
William M McDonald
,
Philip Boyce
,
Paul E Holtzheimer
,
F Andrew Kozel
,
Patricio Riva-Posse
,
Anthony Rodgers
PMID:
39399907
DOI:
10.1192/bjp.2024.189
No abstract available
Publication types
Letter